NH

NantHealth
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.650
-0.150
-5.36%
Closed 16:30 06/16 EDT
OPEN
2.780
PREV CLOSE
2.800
HIGH
2.830
LOW
2.610
VOLUME
96.19K
TURNOVER
--
52 WEEK HIGH
6.60
52 WEEK LOW
1.930
MARKET CAP
300.51M
P/E (TTM)
-3.1034
1D
5D
1M
3M
1Y
5Y
Where Do Hedge Funds Stand On NantHealth, Inc. (NH)?
In this article we are going to use hedge fund sentiment as a tool and determine whether NantHealth, Inc. (NASDAQ:NH) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedg...
Insider Monkey · 2d ago
8-K: NantHealth, Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 05/06 23:52
NantHealth EPS misses by $0.01, misses on revenue
NantHealth (NH): Q1 Non-GAAP EPS of -$0.09 misses by $0.01; GAAP EPS of -$0.14 misses by $0.01.Revenue of $16.17M (-11.1% Y/Y) misses by $0.79M.Press Release
Seekingalpha · 05/06 20:49
NantHealth Q1 Adj. EPS $(0.09) Misses $(0.07) Estimate, Sales $16.20M Miss $18.33M Estimate
NantHealth (NASDAQ:NH) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 50 percent decrease over losses of $(0.06) per share from the same
Benzinga · 05/06 20:36
NantHealth Reports 2021 First Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its first quarter ended March 31, 2021.
BusinessWire · 05/06 20:05
NantHealth, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 6, 2021 / NantHealth, Inc. (NASDAQ:NH) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time.
ACCESSWIRE · 05/06 18:52
-- Earnings Flash (NH) NANTHEALTH Posts Q1 Revenue $16.2M, vs. Street Est of $17M
MT Newswires · 05/06 16:10
A Preview Of NantHealth's Earnings
NantHealth (NASDAQ:NH) unveils its next round of earnings this Thursday, May 06. Get prepared with Benzinga's ultimate preview for NantHealth's Q1 earnings.
Benzinga · 05/05 14:08
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NH. Analyze the recent business situations of NantHealth through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NH stock price target is 3.750 with a high estimate of 4.000 and a low estimate of 3.500.
EPS
Institutional Holdings
Institutions: 67
Institutional Holdings: 6.56M
% Owned: 5.79%
Shares Outstanding: 113.40M
TypeInstitutionsShares
Increased
19
431.61K
New
5
95.26K
Decreased
15
305.08K
Sold Out
9
460.40K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.39%
Healthcare Equipment & Supplies
-0.15%
Key Executives
Chairman/Chief Executive Officer/Founder/Director
Patrick Soon-Shiong
Chief Financial Officer/Chief Accounting Officer
Bob Petrou
Chief Operating Officer
Ronald Louks
Independent Director
Michael Blaszyk
Independent Director
Kirk Calhoun
Independent Director
Michael Sitrick
Independent Director
Deanna Wise
No Data
About NH
NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. It conducts its operations primarily in the United States, Canada, the United Kingdom and Singapore. Its solutions include molecular profiling solution, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine, enabling care and clinical practice. Its cancer care solutions include a set of interoperability, diagnostics, risk stratification and decision support solutions (Eviti). Its systems infrastructure collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from sources to improve decision-making. Its subsidiary, OpenNMS Group, Inc, provides fault, performance and traffic monitoring solutions.

Webull offers kinds of NantHealth Inc stock information, including NASDAQ:NH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NH stock methods without spending real money on the virtual paper trading platform.